Showing results (51-60 of 111) with videos related to

Sort By:
Pageof 12
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|May 23, 2003
[Application of ultrasound-guided percutaneous radiofrequency ablation in treatment of liver cancer]Xiao-yan Xie, Ming-de Lü, Xiao-yu Yin, et al.
The Journal of Surgical Research|October 5, 2025
Machine Learning Algorithm-Based Tumor-Stroma Ratio Can Stratify the Prognosis of Intrahepatic CholangiocarcinomaXin Zhang, Chen-Song Huang, Xi-Tai Huang, et al.
Cancer Letters|June 22, 2022
ACLP promotes activation of cancer-associated fibroblasts and tumor metastasis via ACLP-PPARγ-ACLP feedback loop in pancreatic cancerYa-Xiong Li, Xiao-Xu Zhu, Xiao Wu, et al.
Gastroenterology Report|March 13, 2023
Values of debulking surgery for unresectable well-differentiated metastatic pancreatic neuroendocrine tumors: a comparative studyXi-Tai Huang, Jin-Zhao Xie, Liu-Hua Chen, et al.
Gastroenterology Report|October 20, 2022
Values of spleen-preserving distal pancreatectomy in well-differentiated non-functioning pancreatic neuroendocrine tumors: a comparative studyXi-Tai Huang, Jin-Zhao Xie, Jian-Peng Cai, et al.
Annals of Surgical Oncology|July 7, 2012
Percutaneous ablative therapies of recurrent hepatocellular carcinoma after hepatectomy: proposal of a prognostic modelXiao-Yu Yin, Xiao-Yan Xie, Ming-De Lu, et al.
Cancer Letters|February 20, 2018
The C/EBPβ-LINC01133 axis promotes cell proliferation in pancreatic ductal adenocarcinoma through upregulation of CCNG1Chen-Song Huang, Junjun Chu, Xiao-Xu Zhu, et al.
Chinese Journal of Cancer|July 30, 2016
EYA4 gene functions as a prognostic marker and inhibits the growth of intrahepatic cholangiocarcinomaXiao-Yi Hao, Jian-Peng Cai, Xin Liu, et al.
Cancer Letters|July 16, 2021
HNRNPC impedes m<sup>6</sup>A-dependent anti-metastatic alternative splicing events in pancreatic ductal adenocarcinomaXi-Tai Huang, Jian-Hui Li, Xiao-Xu Zhu, et al.
Journal of Robotic Surgery|January 4, 2024
Robotic-assisted organ-preserving or parenchymal-sparing pancreatectomy in pancreatic benign or low-grade malignant tumors: a single institute's experienceXi-Tai Huang, Xiao-Fei Qu, Jia-Wei Zhou, et al.
Pageof 12